Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04329533 · ClinicalTrials.gov registry record · NA

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT04329533: Completed NA study, sponsored by University of Arizona.

NCT04329533 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04329533, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

Due to the COVID-19 global health pandemic, many people are likely experiencing increased stress. Many obstetrics and gynecology patients are additionally experiencing increased stress due to the healthcare changes the COVID-19 pandemic has caused including delayed or canceled elective surgeries, visitor restrictions, and telemedicine visits instead of in person clinic visits. Mindfulness meditation is a self-management strategy that can be utilized by anyone to assist with the management of stress. Mindfulness meditation mobile applications, such as the "Calm" app, can be used to help manage stress, especially during this uncertain time. The investigators propose a prospective randomized controlled trial evaluating perceived stress, anxiety, and sleep disturbance in the investigators outpatient OB/Gyn patients at Banner Women's Institute, with the use of a 30 day trial of the mindfulness meditation app, "Calm." All patients would ultimately receive a 30 day free trial of the mobile meditation app, however the intervention group would receive the 30-day free trial immediately and the control group would receive the 30-day free trial after the study period which is 30 days after enrollment. The investigators additionally want to evaluate the feasibility of using the mobile app, including looking at adherence to use of the app and patient satisfaction with use of the app.

Primary Outcome

Validated perceived stress scale survey, 10 questions in length rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. Individual scores can range from 0 to 40 with higher scores indicating higher perceived stress.

Interventions

  • OTHER "Calm" is a mindfulness meditation mobile app

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2020-04-13
Est. Completion 2020-11-01
Phase NA
University of Arizona

349 total trials

What the finished NCT04329533 record still lists

NCT04329533 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which "Calm" is a mindfulness meditation mobile app is the first listed.

NCT04329533 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04329533 about?

NCT04329533 is a clinical study titled "Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic". Due to the COVID-19 global health pandemic, many people are likely experiencing increased stress. Many obstetrics and gynecology patients are additionally experiencing increased stress due to the healthcare changes the COVID-19 pandemic has caused including delayed or canceled elective surgeries, vi...

What is the current status of trial NCT04329533?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2020-04-13. Estimated completion is 2020-11-01.

What interventions are being tested in trial NCT04329533?

The interventions under investigation include: "Calm" is a mindfulness meditation mobile app (OTHER).

Who is sponsoring clinical trial NCT04329533?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04329533's enrollment target sits among peer trials

101 840th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04329533, the US trial registry maintained by the National Library of Medicine. NCT04329533 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.